Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 11
2003 3
2004 3
2005 3
2006 3
2007 4
2008 4
2009 6
2010 4
2011 5
2012 5
2013 5
2014 6
2015 10
2016 3
2017 6
2018 3
2019 10
2020 15
2021 12
2022 11
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Improving the EASIX' predictive power for NRM in adults undergoing allogeneic hematopoietic cell transplantation.
Escribano-Serrat S, Rodríguez-Lobato LG, Suárez-Lledó M, Pedraza A, Charry P, Cid J, Lozano M, Esteve J, Rosiñol L, Fernández-Avilés F, Carreras E, Díaz-Ricart M, Martínez C, Rovira M, Salas MQ. Escribano-Serrat S, et al. Among authors: diaz ricart m. Bone Marrow Transplant. 2024 Mar 23. doi: 10.1038/s41409-024-02267-6. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38521886 No abstract available.
EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation.
Tolosa-Ridao C, Cascos E, Rodríguez-Lobato LG, Pedraza A, Suárez-Lledó M, Charry P, Solano MT, Martinez-Sanchez J, Cid J, Lozano M, Rosiñol L, Esteve J, Urbano-Ispizua Á, Fernández-Avilés F, Martínez C, Carreras E, Díaz-Ricart M, Rovira M, Salas MQ. Tolosa-Ridao C, et al. Among authors: diaz ricart m. Bone Marrow Transplant. 2024 Mar 23. doi: 10.1038/s41409-024-02270-x. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38521885
Antithrombotic and prohemorrhagic actions of different concentrations of apixaban in patients exposed to single and dual antiplatelet regimens.
Martinez-Sanchez J, Castrillo L, Jerez D, Torramade-Moix S, Palomo M, Mendieta G, Zafar MU, Moreno-Castaño AB, Sanchez P, Badimon JJ, Diaz-Ricart M, Escolar G, Roqué M. Martinez-Sanchez J, et al. Among authors: diaz ricart m. Sci Rep. 2023 Dec 27;13(1):22969. doi: 10.1038/s41598-023-50347-2. Sci Rep. 2023. PMID: 38151494 Free PMC article.
Endothelial activation and damage as a common pathological substrate in different pathologies and cell therapy complications.
Palomo M, Moreno-Castaño AB, Salas MQ, Escribano-Serrat S, Rovira M, Guillen-Olmos E, Fernandez S, Ventosa-Capell H, Youssef L, Crispi F, Nomdedeu M, Martinez-Sanchez J, De Moner B, Diaz-Ricart M. Palomo M, et al. Among authors: diaz ricart m. Front Med (Lausanne). 2023 Nov 14;10:1285898. doi: 10.3389/fmed.2023.1285898. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38034541 Free PMC article. Review.
Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation.
Pedraza A, Salas MQ, Rodríguez-Lobato LG, Escribano-Serrat S, Suárez-Lledo M, Martínez-Cebrian N, Solano MT, Arcarons J, Rosiñol L, Gutiérrez-García G, Fernández-Avilés F, Moreno-Castaño AB, Molina P, Pino M, Carreras E, Díaz-Ricart M, Rovira M, Palomo M, Martínez C. Pedraza A, et al. Among authors: diaz ricart m. Transplant Cell Ther. 2024 Feb;30(2):187.e1-187.e12. doi: 10.1016/j.jtct.2023.11.016. Epub 2023 Nov 23. Transplant Cell Ther. 2024. PMID: 38000709
Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis.
Escribano-Serrat S, Rodríguez-Lobato LG, Charry P, Martínez-Cibrian N, Suárez-Lledó M, Rivero A, Moreno-Castaño AB, Solano MT, Arcarons J, Nomdedeu M, Cid J, Lozano M, Pedraza A, Rosiñol L, Esteve J, Urbano-Ispizua Á, Palomo M, Fernández-Avilés F, Martínez C, Díaz-Ricart M, Carreras E, Rovira M, Salas MQ. Escribano-Serrat S, et al. Among authors: diaz ricart m. Cytotherapy. 2024 Jan;26(1):73-80. doi: 10.1016/j.jcyt.2023.10.008. Epub 2023 Nov 10. Cytotherapy. 2024. PMID: 37952139
Real-world data of the use and experience of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura: Case series.
Albanell-Fernández M, Monge-Escartín I, Carcelero-San Martín E, Riu Viladoms G, Ruiz-Boy S, Lozano M, Soy D, Moreno-Castaño AB, Diaz-Ricart M, Cid J. Albanell-Fernández M, et al. Among authors: diaz ricart m. Transfus Apher Sci. 2023 Jun;62(3):103722. doi: 10.1016/j.transci.2023.103722. Epub 2023 May 8. Transfus Apher Sci. 2023. PMID: 37169697 Review.
Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis.
Moreno-Castaño AB, Fernández S, Ventosa H, Palomo M, Martinez-Sanchez J, Ramos A, Ortiz-Maldonado V, Delgado J, Fernández de Larrea C, Urbano-Ispizua A, Penack O, Nicolás JM, Téllez A, Escolar G, Carreras E, Fernández-Avilés F, Castro P, Diaz-Ricart M. Moreno-Castaño AB, et al. Among authors: diaz ricart m. J Immunother Cancer. 2023 Apr;11(4):e006365. doi: 10.1136/jitc-2022-006365. J Immunother Cancer. 2023. PMID: 37045474 Free PMC article.
122 results